Aster DM Healthcare Reports Mixed Financial Results Amidst Profit Growth and Sales Decline in March 2025
Aster DM Healthcare's financial results for the quarter ending March 2025 reveal a significant increase in Profit After Tax, while Profit Before Tax has declined. Additionally, net sales have decreased year-on-year, indicating a mixed performance landscape for the company amid ongoing financial dynamics.
Aster DM Healthcare has recently reported its financial results for the quarter ending March 2025, revealing a complex picture of performance within the large-cap hospital industry. The company's Profit After Tax (PAT) has shown remarkable growth, reaching Rs 103.98 crore, which reflects a significant year-on-year increase of 7783.1%. This positive trend in PAT indicates a strong near-term outlook for profitability.However, the financial results also highlight challenges for Aster DM Healthcare. The Profit Before Tax (PBT), excluding other income, has experienced a decline, reported at Rs 85.68 crore, marking a year-on-year decrease of 23.60%. Additionally, net sales over the latest six months stand at Rs 2,050.15 crore, which represents a year-on-year decline of 56.23%. These contrasting trends suggest a mixed performance landscape for the company.
In light of these results, Aster DM Healthcare has undergone an adjustment in its evaluation, with its score shifting to -4 from -17 over the past three months. This revision reflects the ongoing dynamics within the company's financial performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
